ACCC 47th Annual Meeting & Cancer Center Business Summit

We are experiencing a year of unprecedented change in our healthcare system. The impact of the COVID-19 pandemic on how patients access—and cancer programs deliver—cancer care, dramatic shifts in staffing, and the urgent need for revenue optimization in a volatile economic environment are just a few of the challenges facing cancer programs and practices in 2020—and beyond.

The ACCC 47th Annual Meeting & Cancer Center Business Summit, March 1 – 5, 2021, will be a fully virtual experience that will deliver a focused look at the hot-button issues impacting your cancer program today, and the strategies you’ll need to emerge positioned for success tomorrow.

AMCCBS Virtual will examine timely, real-world case studies from organizations that used the opportunity created by this crisis to forge a new path forward. They’ll demonstrate how to lead your cancer program or practice through change by accelerating digital health capabilities, transforming business operations and care processes, and enhancing the patient and provider experience. Sessions will explore these focus areas—and more:

  • Cancer Care in the COVID-19 Era
  • Telehealth, Virtual Care Models, and Remote Monitoring
  • Cancer Service Line Efficiency and Revenue Optimization
  • Financial Impact of the Radiation Oncology Model
  • Managing for Success
  • New Models in Clinical Trials and Cancer Research
  • The Next Wave in Oncology Transactions
  • Understanding Antitrust and Oncology
  • Issue of the Day: COVID-19

    Contains 1 Component(s)

    Monday, March 1 Networking Event

    Moderated discussion groups enable attendees to connect with like-minded peers and ask questions related to the day's sessions. 

    Michael Kolodziej, MD, Vice President and Chief Innovation Officer, ADVI Health (Moderator)

  • Day 2 Track 1

    Contains 7 Component(s)

    Tuesday, March 2

    Policy Considerations for Adopting and Expanding Telehealth at Your Cancer Program

    Frank Micciche, Vice President, Public Policy and Communications, National Committee for Quality Assurance
    Feyi Olopade Ayodele, MBA, Chief Executive Officer, Cancer IQ, Inc.
    Mei Wa Kwong, JD, Executive Director, Center for Connected Health Policy
    Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client and Corporate Resources, Revenue Cycle Coding Strategies (Moderator)

    This panel conversation will explore policy considerations for cancer programs looking to expand and sustain their telehealth services. Panelists will discuss reimbursement and regulatory barriers, lessons learned and opportunities in the current era, the status of provisions after the public health emergency ends, healthcare disparities, and the policies that are still required to ensure long-term adoption of telehealth.

    Virtual Solutions: Oncology Telemedicine for Rural Communities

    Johanna Garzon, MHA, HBAT, Cancer Center Director, Central Care Cancer Center and Heartland Cancer Center

    While most cancer programs adopted telehealth virtually overnight, challenges still exist, and lessons learned from telehealth programs established pre-pandemic can help. Hear strategies to address challenges around access to technology, socio-economic barriers, and standardization. Learn how to improve health equity by ensuring non-English speaking patients and those with limited financial resources can effectively access these services.

    The Role of Remote Cancer Symptom Management in An Evolving Reimbursement Landscape

    Ethan Basch, MD, MSc, Chief, Division of Oncology; Physician-in-Chief NC Cancer Hospital; Professor, Health Policy and Management, UNC Gillings School of Global Public Health; Director, Cancer Outcomes Research Program; Co-Leader, Cancer Prevention and Control Program, Control Program, Lineberger Comprehensive Cancer Center
    Nadia Still, DNP, RN, Senior Director of Client Services, Carevive Systems, Inc.
    Madelyn Trupkin Herzfeld, Founder and Vice Chair, Carevive Systems, Inc.
    Bruno Lempernesse, Chief Executive Officer, Carevive Systems, Inc.

    Learn about the latest research findings on patient-reported outcomes (PROs), the role of remote symptom management (RSM) in an evolving reimbursement landscape, how to implement RSM in your practice, and how to use insights from patient experience data to inform the future of cancer care.

    Prevention on the Go—Workplace

    Renea Austin-Duffin, MPA, Vice President, Cancer Support, Outreach & Clinical Research, Mary Bird Perkins Cancer Center

    With the precipitous drop in screenings in the spring of 2020, COVID-19 has had a catastrophic impact on cancer screening and prevention. Learn from the changes this program made to continue to offer these critical services to at-risk patients, including education on how mobile vans can offer a safe—and more comfortable— alternative for people hesitant to return to the clinic.

  • Day 2 Track 2

    Contains 6 Component(s)

    Tuesday, March 2

    Policy Considerations for Adopting and Expanding Telehealth at Your Cancer Program

    Frank Micciche, Vice President, Public Policy and Communications, National Committee for Quality Assurance
    Feyi Olopade Ayodele, MBA, Chief Executive Officer, Cancer IQ, Inc.
    Mei Wa Kwong, JD, Executive Director, Center for Connected Health Policy
    Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client and Corporate Resources, Revenue Cycle Coding Strategies (Moderator) 

    This panel conversation will explore policy considerations for cancer programs looking to expand and sustain their telehealth services. Panelists will discuss reimbursement and regulatory barriers, lessons learned and opportunities in the current era, the status of provisions after the public health emergency ends, healthcare disparities, and the policies that are still required to ensure long-term adoption of telehealth.

    Cancer Care During the Pandemic: The Good, the Bad, and the Ugly from the Patient Perspective

    Elizabeth F. Franklin, PhD, MSW, Executive Director, Cancer Policy Institute, Cancer Support Community
    Shelley Fuld Nasso, MPP, Chief Executive Officer, National Coalition for Cancer Survivorship
    Michael Kolodziej, MD, Vice President and Chief Innovation Officer, ADVI Health (Moderator)

    The rapid adoption of telehealth that enabled cancer programs to continue to care for patients during the pandemic is widely and extensively praised. But this acclaim is largely testimonial and anecdotal—and generally from providers. But what do patients think? What’s working in telehealth and what’s not? Is telehealth really going to become standard practice in the post-pandemic? The patient advocacy groups represented on this panel have studied telehealth from the patient perspective and will share their findings with the goal of improving patient care.

    Video Visits to Virtual Care Centers: The Evolving Digital Opportunity 

    Royce Cheng, Principal, The Chartis Group 
    Kelley D. Simpson, MBA, Director, Chartis Oncology Solutions Leader, The Chartis Group

    Gain information on virtual technologies and supporting digital tools with enduring value beyond the present pandemic, including ePROs, virtual care navigation, tumor boards, consultations, follow-up, and supportive care services. Learn reasons to support increased adoption of virtual care modalities, including the opportunity to dramatically expand care access beyond physical subspecialty hubs, promote screening in the face of significant declines in new cancer detection rates, and mitigate risks for patients.

    Hear strategic drivers for adopting virtual care, such as improved resource efficiency and productivity, and clinical and research program growth through improved new patient consults and clinical trial access. Learn how to develop a virtual care center which serves as an operational hub for clinical expertise, service capabilities, and intellectual capital outside of traditional geographic constraints.

    Keeping Patients Connected to Telegenetics—During and Beyond COVID-19

    image 
    This session is sponsored by InformedDNA.

    Mallory Kirby, Senior Analyst, The Advisory Board Company
    Rachel McConachie, RN, BSN, Clinical Operations Director, Dignity Health Cancer Institute
    Ashley Navarro, MS, LCGC, Board Certified Genetic Counselor (ABGC); Genetic Counseling Manger, Dignity Health Cancer Institute

    Hear short- and long-term benefits of tele-genetic counseling, including expanded access, remote patient engagement, reduced administrative burden, and improved collaboration between genetic counselors and providers. Learn practical strategies to successfully implement a tele-genetic counseling program and integrate it into workflows. Understand how to leverage the Cancer IQ genetic cancer risk assessment platform to remotely screen patients for genetic cancers and deliver virtual genetic counseling sessions.

  • Innovation Showcase: Telehealth, Virtual Care Models, and Remote Monitoring

    Contains 2 Component(s)

    Tuesday, March 2

    Telehealth, Virtual Care Models, and Remote Monitoring

    Four consecutive presentations of product and service solutions pertinent to the topic-of-the-day will be followed by a moderated Q&A discussion with the speakers in regard to the solutions offered.

    OncoAIR
    Lauren Sutton, Senior Product Manager, Flatiron Health 

    AssistPoint
    Unleashing the Power of Financial Assistance Cycle Management
    Joe Baffone, Co-Founder and Chief Executive Officer, Annexus Health

    Navigating Cancer
    Improving Patient Outcomes: An Integrated and Intelligent PRM Platform
    Lalan Wilfong, MD, Executive Vice President, Value Based Care and Quality Programs, Texas Oncology

    Gitesh Patel, Chief Executive Officer, Sargas Pharmaceutical Adherence & Compliance International (Moderator)

  • Issue of the Day: Telehealth, Virtual Care Models, and Remote Monitoring

    Contains 1 Component(s)

    Tuesday, March 2 Networking Event

    Moderated discussion groups enable attendees to connect with like-minded peers and ask questions related to the day's sessions. 

    Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders (Moderator)

  • Day 3 Track 1

    Contains 7 Component(s)

    Wednesday, March 3

    Cancer Service Line Efficiency and Revenue Optimization

    Nina Chavez, MBA, FACMPE, Head of VBC Solutions and Transformation, Flatiron Health

    Optimizing Revenues and Outcomes

    Kathy Oubre, MS, Chief Operations Officer, Pontchartrain Cancer Center
    Jaclyn Truelove, CRCE-I, Director of Payer Relations and Contracting, Cancer Care Associates of York
    Nina Chavez MBA, FACMPE, Head of VBC Solutions and Transformation, Flatiron Health (Moderator)

    A Dedicated Oncology Revenue Integrity Analyst Improves Revenue Collection and Mitigates Losses

    image
    This session is sponsored by Ciox.

    Catherine L. Lowe, MBA, CPC-A, Oncology Revenue Integrity Analyst, Maine Medical Center Cancer Institute

    With the devastating economic impact that COVID-19 has had on our healthcare system, cancer programs cannot afford to leave money on the table. Learn how to ensure accuracy in pre-registration, registration, prior authorizations, benefits investigations, coding, and claim data. Improve the accuracy of the charge master, with special attention given to new, non-formulary medications. Hear how to communicate effectively with all team members to ensure quick and agile responses to potential issues that can cause financial loss, including off-label medicine use, and to educate patients about all available financial assistance resources.

    Oncology Capture of Emergency Department Patients with Incidental Radiologic Findings

    image

    This session is sponsored by LeanTaaS.

    Nicholas Garland, MS, Administrative Fellow, Vanderbilt University Medical Center
    Katharine Klar, RN, BSN, Assistant Nurse Manager, Vanderbilt University Medical Center

    Cancer programs that struggle to ramp up screening and prevention efforts in a COVID-19 world will benefit from hearing about the development and implementation of a structured process for ED incidental radiologic imaging. Hear how this process ensures follow-up and referral to the appropriate subspecialties, improves patient care and provides a financial incentive through additional visits, procedures, surgeries, radiology, labs, and pathology.


  • Day 3 Track 2

    Contains 8 Component(s)

    Wednesday, March 3

    Cancer Service Line Efficiency and Revenue Optimization

    Nina Chavez, MBA, FACMPE, Head of VBC Solutions and Transformation, Flatiron Health

    Precision Cancer Care for Older Adult Oncology Patients: Digitalizing a System-Wide Geriatric Screening and Intervention Program

    Martine Extermann, MD, PhD, Program Leader, Senior Adult Oncology Program, Moffitt Cancer Center 

    With the risk that COVID-19—and other contagious diseases—have for older patients with cancer, virtual screening can help keep patients out of the clinic while ensuring they receive important clinical and supportive interventions through telehealth visits. Learn how this digital, evidence-based screening tool identifies at risk-patients and then tailors interventions to improve the patient experience and patient outcomes.

    Care Code: Innovative Stress Relief for Oncology Staff

    image

    This session is sponsored by LeanTaaS.

    Laura Himmelstein, LCSW, Coordinator, Caregiver Support and Healing Touch Programs, White Plains Hospital
    Mary Beth Schmidt, MA, BCC, Senior Staff Chaplain, White Plains Hospital

    To protect their most valuable asset—its employees—cancer programs must understand how to screen and identify signs of burnout, vicarious trauma, and stress among cancer care team members. Learn how to develop and disseminate effective self-care strategies that address the emotional, physical, and spiritual health of staff. Hear how to foster a culture that prioritizes well-being, including how to obtain buy-in and support from members of the C-suite and other leadership.

    Results from a National Survey of the Financial Impact of the Radiation Oncology Model

    image

    This session is sponsored by Radiation Business Solutions.

    Sally Eggleston, MBA, RT(T), Vice President, Integration, Radiation Business Solutions

  • Innovation Showcase: Operational Efficiencies and Revenue Optimization

    Contains 2 Component(s)

    Wednesday, March 3

    Operational Efficiencies and Revenue Optimization

    Four consecutive presentations of product and service solutions pertinent to the topic-of-the-day will be followed by a moderated Q&A discussion with the speakers in regard to the solutions offered.

    Flatiron Assist
    Shawn Huda, Senior Product Manager, Flatiron Health
    Rebecca Maniago, PharmD, BCOP, Senior Clinical Pharmacist, Flatiron Health

    LeanTaaS: iQueue for Infusion Centers - Optimizing Infusion Scheduling
    Pamela F. Tobias, MS, RHIA, CHDA, Head of Customer Success, Infusion, LeanTaaS

    ION Solutions
    Rick Lozano, Vice President of Biosimilars and Integrated Busines Development, AmerisourceBergen

    Unlimited Systems: Revenue Cycle Technology/Services
    Emily Rost, Software Sales Specialist, Unlimited Systems

    Ron DiGiaimo, MBA, FACHE, Chairman, Revenue Cycle Coding Strategies (Moderator)

  • Issue of the Day: Operational Efficiency and Revenue Optimization

    Contains 1 Component(s)

    Wednesday, March 3 Networking Event

    Moderated discussion groups enable attendees to connect with like-minded peers and ask questions related to the day's sessions. 

    Nina Chavez, MBA, FACMPE, Head of VBC Solutions and Transformation, Flatiron Health (Moderator)